Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Pierce

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Scientific Reports|February 3, 2021
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine designAlla Amcheslavsky, Aaron L Wallace, Monir Ejemel, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Frontiers in Immunology|September 29, 2022
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variantsQi Li, Fiachra Humphries, Roxie C Girardin, et al.
Nature Communications|April 15, 2020
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomasJay Daniels, Peter G Doukas, Maria E Martinez Escala, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Engineering HIV antibodies with enhanced breadth and potency of neutralization through multistate affinity maturationMateusz Kędzior, Swastik Phulera, Monica L Fernández-Quintero, et al.
Nature Communications|October 23, 2023
SARS-CoV-2 infection establishes a stable and age-independent CD8<sup>+</sup> T cell response against a dominant nucleocapsid epitope using restricted T cell receptorsCecily Choy, Joseph Chen, Jiangyuan Li, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIVMohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Cancer Discovery|July 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy EfficacyZachary Z Reinstein, Yue Zhang, Oscar E Ospina, et al.
Structure (London, England : 1993)|May 15, 2025
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIVMohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Scientific Reports|February 3, 2021
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine designAlla Amcheslavsky, Aaron L Wallace, Monir Ejemel, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Frontiers in Immunology|September 29, 2022
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variantsQi Li, Fiachra Humphries, Roxie C Girardin, et al.
Nature Communications|April 15, 2020
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomasJay Daniels, Peter G Doukas, Maria E Martinez Escala, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Engineering HIV antibodies with enhanced breadth and potency of neutralization through multistate affinity maturationMateusz Kędzior, Swastik Phulera, Monica L Fernández-Quintero, et al.
Nature Communications|October 23, 2023
SARS-CoV-2 infection establishes a stable and age-independent CD8<sup>+</sup> T cell response against a dominant nucleocapsid epitope using restricted T cell receptorsCecily Choy, Joseph Chen, Jiangyuan Li, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIVMohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Cancer Discovery|July 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy EfficacyZachary Z Reinstein, Yue Zhang, Oscar E Ospina, et al.
Structure (London, England : 1993)|May 15, 2025
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIVMohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Pageof 11